BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA | Patent Publication Number 20220265710

US 20220265710 A1

Patent Number-

Application Number17540736

Filled DateDec 2, 2021

Priority DateDec 2, 2021

Publication DateAug 25, 2022

Original Assignee

Current AssigneeJanssen Biotech Inc.

Inventor/ApplicantsXiaohu FAN
Jordan Mark SCHECTER

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.